A zebrafish seizure model of cblX syndrome reveals a dose-dependent refractory response to mTor inhibition.
Claudia B. Gil, David Paz, Briana E. Pinales, Victoria L. Castro, Claire E. Perucho, Annalise V. Gonzales, Giulio Francia, Sepiso Kenias Masenga, Antentor Othrell Hinton Jr., Anita M. Quintana
This study uses a zebrafish model of cblX syndrome to show that mTor inhibition at moderate doses reduces seizure severity, but higher doses cause a refractory response in hcfc1a mutants.
Journal of Developmental Biology · Dec 25, 2025Peer-reviewedDevelopmental Biology